Risk-Benefit Perspectives in COX-2 Blockade

E-ISSN： 2212-3911|3|1|14-23

ISSN： 1574-8863

Source： Current Drug Safety, Vol.3, Iss.1, 2008-01, pp. : 14-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RFID-enabled healthcare systems: risk-benefit analysis

By Mehrjerdi Yahia Zare

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 4, Iss. 3, 2010-09 ,pp. : 282-300

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Selective COX-2 Inhibitors and Risk of Myocardial Infarction

Journal of Vascular Research, Vol. 42, Iss. 4, 2005-07 ,pp. : 312-324

Karger

Access to resources Recommend Favorite

Risk-Benefit Analysis of Combination Versus Unopposed HRT in Post-Menopausal Women

International Journal of User-Driven Healthcare (IJUDH), Vol. 1, Iss. 4, 2011-10 ,pp. : 61-76

IGI Global_journal

Access to resources Recommend Favorite

Vaginal birth after cesarean and trial of labor after cesarean: what should we be recommending relative to maternal risk:benefit?

By Clark Shannon M Carver Alissa R Hankins Gary DV

Women's Health, Vol. 8, Iss. 4, 2012-07 ,pp. : 371-383

Future Medicine

Access to resources Recommend Favorite

Risk–benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 4, 2015-04 ,pp. : 436-443

John Wiley & Sons Inc

Access to resources Recommend Favorite